Tag: 2016

  • Fiona Bruce – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Fiona Bruce – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Fiona Bruce on 2016-05-03.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what the Government’s policy is on voting in favour of referring as genocide the acts committed by Daesh in Iraq and Syria to the International Criminal Court in the event of another member of the UN Security Council proposing such a referral.

    Mr Tobias Ellwood

    It is not possible for the UN Security Council to refer Daesh itself to the International Criminal Court (ICC). Any referral would cover all potential crimes within a specified geographic area, rather than by a specified organisation or set of actors.

    We would consider carefully any suggestion from another member of the Security Council to refer the situation in Iraq and Syria to the ICC.

    However, we judge that a referral to the International Criminal Court by the UN Security Council is not practical at this time.

    When efforts were made to refer the situation in Syria to the ICC in 2014, it was vetoed by Russia and China. We expect that any Security Council resolution at this time seeking to refer the situations in Iraq or Syria to the ICC would likewise be blocked.

    We continue to discuss with partners on the UN Security Council further ways to ensure that the perpetrators of crimes committed in Syria and Iraq are held to account and face justice.

  • Jim Cunningham – 2016 Parliamentary Question to the Department of Health

    Jim Cunningham – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Cunningham on 2016-06-15.

    To ask the Secretary of State for Health, pursuant to the Answer of 13 June 2016 to Question 40017, on NHS: drugs, what the value is of the five contracts listed in that Answer.

    George Freeman

    We cannot provide the values of the contracts because it is possible that such information, if taken with other information already in the public domain, may make it possible to deduce the purchase prices of the products concerned. Suppliers will regard product pricing as commercially sensitive. The publication of commercially sensitive drugs pricing information is likely to prejudice the commercial interests of the contractors concerned as well as those of the Department itself.

  • Tim Farron – 2016 Parliamentary Question to the Department of Health

    Tim Farron – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Tim Farron on 2016-09-12.

    To ask the Secretary of State for Health, how many doctors have taken the Royal College of General Practitioners online awareness module on Lyme disease.

    Mr Philip Dunne

    The Department does not hold this information.

  • Madeleine Moon – 2016 Parliamentary Question to the Department for International Development

    Madeleine Moon – 2016 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by Madeleine Moon on 2016-10-19.

    To ask the Secretary of State for International Development, what anti-corruption measures were agreed at the Brussels Conference on Afghanistan, held on 4-5 October 2016; what steps she plans to take to ensure the effectiveness of such measures; and if she will make a statement.

    Rory Stewart

    Helping Afghans to tackle corruption is a key priority for the UK’s engagement in Afghanistan, where we focus first and foremost on anti-corruption efforts that contribute to the building of a stable and self-reliant state. Anti-corruption was a key theme of the Brussels Conference on Afghanistan. At the Conference, the Afghan government announced that the new Anti Corruption Justice Centre (ACJC) was operational. They also made a commitment that five revenue generating ministries will publicly report on implementation progress of their anti-corruption action plans in 2017.

    The UK and the rest of the international community will continue to press the Afghan government to deliver on these commitments to ensure that core government functions are transparent, accountable and consistent, and that violations are met with legal, timely and consistently applied sanctions.

  • Baroness Tonge – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Baroness Tonge – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Baroness Tonge on 2016-01-18.

    To ask Her Majesty’s Government what assessment they have made of the level of involvement of the British company G4S in running prisons in Israel.

    Baroness Anelay of St Johns

    While the British Government has not made an assessment of the level of involvement of G4S in the running of Israeli prisons, we have made clear in meetings with G4S our concerns about Israel’s conduct of the occupation. In April 2013, G4S publicly confirmed that they would not renew a number of security contracts in the West Bank ‘to ensure that G4S Israel business practices remain in line with our own business ethics policy’. These include the servicing of security equipment at Ofer Military Prison, at West Bank checkpoints and at a police station in the contentious E-1 area of the West Bank.

  • Joan Ryan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Joan Ryan – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Joan Ryan on 2016-02-04.

    To ask the Secretary of State for Foreign and Commonwealth Affairs, what financial assistance his Department has given to the Palestinian Authority in each of the last five years for which information is available.

    Mr Desmond Swayne

    I have been asked to reply.

    The Department for International Development (DfID) provided £349 million in support of Palestinian development from 2011-15 and will provide a further £72 million in 2015-16, of which up to £25.5 million will be provided to the Palestinian Authority. This year, UK aid will support 36,000 children in primary education and support 270 enterprises to improve their annual sales or productivity.

    UK aid is helping the Palestinian Authority to develop strong institutions, deliver essential public services and improve security – building the foundations for a sovereign and viable Palestinian state living alongside Israel in peace and security. For a breakdown on how financial assistance in the Palestinian Territories is spent, information is published on DfID’s Development Tracker website at https://devtracker.dfid.gov.uk.

    “

  • Lord Walton of Detchant – 2016 Parliamentary Question to the Department of Health

    Lord Walton of Detchant – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Walton of Detchant on 2016-03-01.

    To ask Her Majesty’s Government whether appropriate treatment for patients with plasma disorders such as haemophilia and primary immunodeficiency, as provided for under the statutory scheme for branded medicines, will continue to be provided following the review of that scheme by the Department of Health.

    Lord Prior of Brampton

    We are continuing to consider carefully all the consultation responses. It is important we get these changes right for patients, the National Health Service and industry. We want to look in particular at the impact on small and medium sized businesses, while securing the medicines patients need at a cost which the NHS can afford.

  • Ian Murray – 2016 Parliamentary Question to the Cabinet Office

    Ian Murray – 2016 Parliamentary Question to the Cabinet Office

    The below Parliamentary question was asked by Ian Murray on 2016-04-08.

    To ask the Minister for the Cabinet Office, what the share of income of the top one per cent of earners in Scotland was in each year since 1990.

    Mr Rob Wilson

    The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

  • Paula Sherriff – 2016 Parliamentary Question to the Department of Health

    Paula Sherriff – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Paula Sherriff on 2016-05-03.

    To ask the Secretary of State for Health, what discussions officials of his Department have had with external bodies on the development of a national liver strategy or liver framework; and if he will make a statement.

    Jane Ellison

    Public Health England (PHE) is producing a liver disease framework which will outline PHE’s wide range of work contributing to the prevention of liver disease and improved wellbeing for patients with liver disease. PHE is working closely with NHS England, The Lancet Commission and liver disease charities to support improvements in the quality of care for liver disease patients through the provision of information to support decision making.

  • Joan Ryan – 2016 Parliamentary Question to the Department of Health

    Joan Ryan – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Joan Ryan on 2016-06-15.

    To ask the Secretary of State for Health, what assessment he has made of the implications for his Department of findings of Health Education England’s briefing paper on its inspection visit to North Middlesex University Hospital NHS Trust’s emergency department in March 2016.

    Ben Gummer

    We understand that no announcement has been made by Health Education England (HEE) about ceasing postgraduate training in North Middlesex University Hospital NHS Trust’s emergency department.

    We are determined to make the National Health Service the safest and most transparent healthcare system in the world, transforming patient safety and changing the culture of the NHS to support patients and doctors alike.

    Patient safety is the key concern of the Government. HEE’s role is to ensure that trainees have access to safe, high quality learning. Excellence in healthcare education leads to safe, high quality care for patients in both the short term and the long term.

    HEE continues to work with the Trust, NHS Improvement, NHS England and the General Medical Council (GMC) to support the Trust and ensure it has an achievable action plan for trainees to meet GMC standards.

    HEE has required the Trust to have sufficient middle grade and senior cover so that junior doctors are appropriately supported. The Trust has appointed a Clinical Director to lead the improvement work required. Enhanced oversight arrangements imposed by NHS Improvement and NHS England will ensure that rotas are safely staffed. Additional support has been provided to the Trust by other NHS organisations.